Introduction {#sec1}
============

MiRNAs are 19--24 nts short nucleotide sequences, which could complementarily combine with multiple target sequences and one miRNA could regulate multiple different target genes \[[@B1]\]. Single nucleotide polymorphisms (SNPs) are the common variations in the genetic polymorphisms and are known as the potential biomarkers for predicting the cancer risk \[[@B2]\]. If there is a variation in miRNA gene, it could affect the quality and quantity of mature miRNA and even affect hundreds of targetted genes regulated by the changed miRNA \[[@B3]\]. There are two types of miRNA-SNP: pri-miRNA SNPs and pre-miRNA SNPs. pri-miRNA SNPs are located over approximately 500--3000bp of the miRNA gene, while pre-miRNA SNPs are found in a 60--70bp region. The function of miRNA-SNPs depends on its location; therefore, pri-miRNA SNPs may have more important roles than pre-miRNA SNPs.

Hepatocellular cancer (HCC) is now the second leading cause of cancer deaths worldwide \[[@B4]\]. In HCC patients, approximately 50% are related with Hepatitis B virus (HBV) \[[@B5],[@B6]\], and HBV is still the major cause of HCC, especially in Asia-Pacific and Sub-Saharan Africa \[[@B7]\]. The etiology of HBV-related HCC is reported different from that of no chronic HBV infection, which is mainly caused by the HBV, host-related such as SNPs, and the dietary and lifestyle factors \[[@B8]\]. Thus, the prediction for the HCC risk, especially the HBV-related HCC risk is essential to prevent the incidence of HCC and increase the early diagnosis of HCC.

Until now, several miRNA-SNPs have been reported to be associated with many tumors such as gastric cancer \[[@B9]\], esophageal cancer \[[@B10]\], breast cancer \[[@B11]\], and neuroblastoma \[[@B12]\]. And miRNA-SNPs were also related with HCC risk \[[@B13],[@B14]\] and could be biomarkers for the precaution for HCC risk, but system analysis or update meta-analysis for all the miRNA-SNPs associated with HCC risk was rare, especially the latest research progress. In addition, many studies supplied data about the HBV-related HCC risk, but few meta-analyses considered this important factor with the etiology of HCC incidence. In the present study, we systematically reviewed published data and comprehensively analyzed and integrated all individual studies for miRNA-SNPs and HCC and/or HBV-related HCC risk. On the basis of systematic review, we conducted a meta-analysis to combine all the available studies and to investigate for the five highly studied miRNA-SNPs whether miRNA polymorphisms contribute to the risk of HCC and/or HBV-related HCC risk.

Methods {#sec2}
=======

Publication search {#sec2-1}
------------------

The present study was carried out on the basis of Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) \[[@B15]\]. Studies reporting on the association between the miRNAs polymorphism and HCC risk were identified by entering the following search terms into PubMed and Web of Science: 'miRNA'; and 'polymorphisms/variants/variation/single nucleotide polymorphism/SNPs'; 'hepatocellular'; and 'cancer/carcinoma/tumor/neoplasm' published until 23 February 2018. Two independent investigators (B.-g.W. and Q.X.) performed this literature search. Eligible studies met the following criteria: (i) investigate the relationship between miRNA-SNPs and HCC risk and (ii) case--control study. Articles were excluded based on the following criteria: (i) duplicated articles or data; (ii) not relevant to HCC risk or miRNA-SNPs; (iii) functional studies; and (iv) lack of available data.

Data extraction {#sec2-2}
---------------

Two investigators (B.-g.W. and Q.X.) extracted the data independently and reached consensus regarding all the items. Study descriptions were derived from the full text including the author's name, year of publication, country of origin, source of control groups, genotyping method, total number of the case and control groups and each genotype. Considering parts of the studies supplied data concerning HBV related HCC risk, we collected them for a subgroup analysis.

False-positive report probability analysis and trial sequential analysis {#sec2-3}
------------------------------------------------------------------------

The False-positive report probability (FPRP) values at different prior probability levels for all significant findings were calculated as published reference studies \[[@B16]\]. Briefly, 0.2 was set as FPRP threshold and assigned a prior probability of 0.1 for an association with genotypes under investigation. A FPRP value \<0.2 denoted a noteworthy association.

TSA was performed as described by user manual for trial sequential analysis \[[@B18]\]. After adopting a level of significance of 5% for type I error and of 30% for type II error, the required information size was calculated, and TSA monitoring boundaries were built \[[@B19],[@B20]\].

Statistics analysis {#sec2-4}
-------------------

Hardy--Weinberg equilibrium (HWE) was calculated for control group using the Chi-square test and *P*\<0.05 was considered to be significant disequilibrium. The strength of the association between the miRNA polymorphism and HCC risk was estimated by odds ratios (ORs) with 95% confidence intervals (CIs). In the absence of between-study heterogeneity for Q-statistic *I^2^* \< 50%, fixed-effect model was reported to conserve statistical power, otherwise, the random-effect model was used \[[@B19],[@B20]\]. Risk of publication bias across studies were assessed by Begg's rank correlation and the Egger's linear regression, and if *P*\>0.10 was considered to be lack of publication bias \[[@B21]\]. Sensitivity analysis was conducted by eliminating studies one by one. All analyses were conducted using Stata software 11.0 and the results were considered statistically significant when the *P*-value was less than 0.05.

Results {#sec3}
=======

Characteristics of the eligible studies {#sec3-1}
---------------------------------------

As shown in the flow diagram in [Figure 1](#F1){ref-type="fig"}, a total of 165 articles were included in this systematic review, and finally, 37 researches, 11821 HCC patients and 15359 controls were involved in our meta-analysis after multiple steps of selection ([Figure 1](#F1){ref-type="fig"}). The characteristics of each included study and the genotype frequency distributions of each SNPs are presented in [Table 1](#T1){ref-type="table"}. We also listed the genotype of HBV-related HCC group as data for the subgroup analysis. Then, HWE was calculated and *P* of HWE in control group for several studies did not reach genetic equilibrium, then, studies for *P*~HWE~\<0.05 were excluded in the following analysis.

![Studies identified in this meta-analysis based on the criteria for inclusion and exclusion](bsr-38-bsr20180712-g1){#F1}

###### Characteristics of literature included for this meta-analysis for HCC risk

  Number   First author          Year   Country    Ethnicity   Source of control groups   Genotyping method   hsa-miRNA          Sample size   Case   Control   HBV-related HCC   *P* of HWE in control group   Citation                                                                                   
  -------- --------------------- ------ ---------- ----------- -------------------------- ------------------- ------------------ ------------- ------ --------- ----------------- ----------------------------- ---------- ------ -------------- ------------- ------------- -------------- -------------- ------------
  1        H. Akkız              2011   Turkish    Caucasian   HB                         PCR-RFLP            hsa-*mir-196a-2*   185           185    77        86                22                            58         87     40             46            48            11             0.492          \[[@B49]\]
  2        Hikmet Akkız          2011   Turkish    Caucasian   HB                         PCR-RFLP            hsa-*mir-499*      222           222    45        87                90                            47         93     82                                                        0.950          \[[@B50]\]
  3        Hikmet Akkız          2011   Turkish    Caucasian   HB                         PCR-RFLP            hsa-*mir-146a*     222           222    137       75                10                            144        67     11             75            51            6              0.384          \[[@B51]\]
  4        Yin-Hung Chu          2014   China      Asian       HB                         PCR-RFLP            hsa-*mir-146a*     188           337    22        82                84                            50         146    141            47                          32             0.230          \[[@B24]\]
                                                               PCR-RFLP                   hsa-*mir-196a-2*    188                337           41     81        66                70                            167        100    46                           33            0.986                         
                                                               PCR-RFLP                   hsa-*mir-499*       188                337           119    60        9                 281                           55         1      46                           27            0.321                         
                                                               Real-time PCR              hsa-*mir-149*       188                337           13     36        139               27                            64         246    19                           54            **\<0.001**                   
  5        Ning Cong             2014   China      Asian       HB                         PCR-RFLP            hsa-*mir-146a*     206           218    27        85                94                            17         84     117            15            35            39             0.723          \[[@B52]\]
  6        Yu-Xia Hao            2013   China      Asian       HB                         PCR-RFLP            hsa-*mir-146a*     226           281    23        133               70                            30         154    97                                                        0.056          \[[@B53]\]
                                                                                          hsa-*mir-196a-2*    235                282           77     126       32                67                            160        55     46             71            16            0.051                         
                                                                                          hsa-*mir-499*       235                281           160    51        24                204                           61         16                                                **\<0.001**                   
  7        Won Hee Kim           2012   Korea      Asian       PB                         PCR-RFLP            hsa-*mir-146a*     159           201    14        88                57                            24         103    74             13            71            43             0.190          \[[@B54]\]
                                                                                          hsa-*mir-196a-2*    159                201           34     84        41                45                            107        49     24             70            33            0.356                         
                                                                                          hsa-*mir-499*       159                201           109    47        3                 120                           74         *7*    91             34            2             0.278                         
                                                                                          hsa-*mir-149*       159                201           14     64        81                21                            97         83     68             49            10            0.345                         
  8        Jian-Tao Kou          2014   China      Asian       HB                         PCR-RFLP            hsa-*mir-146a*     271           532    25        147               99                            56         297    179                                                       **\<0.001**    \[[@B25]\]
                                                                                          hsa-*mir-196a-2*    271                532           84     150       37                125                           304        103    56             85            18            **\<0.001**                   
                                                                                          hsa-*mir-499*       271                532           210    49        12                391                           110        31                                                **\<0.001**                   
                                                                                          hsa-*mir-149*       270                532           113    122       35                202                           253        77                                                0.877                         
  9        D. Li                 2015   China      Asian       HB                         PCR-RFLP            hsa-*mir-146a*     184           184    43        83                58                            52         85     47             97 (allele)                 101 (allele)   0.210          \[[@B55]\]
                                                                                          hsa-*mir-499*       184                184           128    39        17                117                           43         24     146 (allele)                 52 (allele)   0.780                         
  10       Juan Li               2016   China      Asian       NM                         Sequencing          hsa-*mir-196a-2*   109           105    25        64                20                            18         52     35                                                        0.861          \[[@B56]\]
  11       Xinhong Li            2015   China      Asian       HB                         PCR-RFLP            hsa-*mir-146a*     266           266    151       86                29                            166        81     19                                                        0.060          \[[@B57]\]
                                                                                          hsa-*mir-196a-2*    266                266           84     131       51                113                           123        30     33                           77            0.689                         
                                                                                          hsa-*mir-499*       266                266           150    92        24                166                           83         17                                                0.140                         
                                                                                          hsa-*mir-149*       266                266           91     130       45                108                           124        34                                                0.864                         
  12       Xiaodong Li           2010   China      Asian       HB                         PCR-RFLP            hsa-*mir-196a-2*   310           222    78        150               82                            42         102    78                                                        0.402          \[[@B58]\]
  13       M.F. Liu              2014   China      Asian       NM                         Sequenom            hsa-*mir-149*      327           327    84        143               100                           56         138    133            109                         23             0.054          \[[@B59]\]
  14       Y.F. Shan             2013   China      Asian       HB                         PCR-RFLP            hsa-*mir-146a*     172           185    28        62                82                            36         71     78             13            25            33             0.080          \[[@B60]\]
                                                                                          hsa-*mir-499*       172                185           128    37        7                 123                           48         14     54             14            3             0.120                         
  15       Eman A. Toraih        2016   Egypt      Caucasian   PB                         Real-time PCR       hsa-*mir-196a-2*   60            150    25        32                3                             80         53     17                                                        0.082          \[[@B61]\]
                                                                                          hsa-*mir-499*       60                 150           28     23        9                 57                            66         27                                                0.307                         
  16       X.H. Wang             2014   China      Asian       HB                         PCR-RFLP            hsa-*mir-499*      152           304    98        32                22                            218        62     24             59            18            12             **\<0.001a**   \[[@B62]\]
                                                                                          hsa-*mir-149*       152                304           13     72        67                43                            148        113    40             42            7             0.623                         
  17       Yu Xiang              2012   China      Asian       HB                         PCR-RFLP            hsa-*mir-146a*     100           100    27        45                28                            21         46     33             18            34            21             0.506          \[[@B63]\]
                                                                                          hsa-*mir-499*       100                100           36     40        24                54                            36         10     27             30            16            0.284                         
  18       Teng Xu               2008   China      Asian       HB                         PCR-RFLP            hsa-*mir-146a*     479           504    80        241               158                           58         249    197                                                       0.119          \[[@B64]\]
  19       Pingping Yan          2015   China      Asian       HB                         PCR-RFLP            hsa-*mir-146a*     274           328    35        145               94                            36         169    123                                                       0.050          \[[@B65]\]
                                                                                          hsa-*mir-196a-2*    274                328           46     147       81                27                            165        136    46             81            41            **0.018a**                    
                                                                                          hsa-*mir-499*       274                328           147    98        29                188                           112        28                                                0.060                         
                                                                                          hsa-*mir-149*       274                328           66     133       75                72                            156        100                                               0.449                         
  20       Jun Zhang             2013   China      Asian       PB                         Sequenom            hsa-*mir-146a*     997           998    163       503               331                           156        475    367            124           390           257            0.911          \[[@B66]\]
                                                                                          hsa-*mir-196a-2*    996                995           214    488       294               165                           502        328    171            376           224           0.245                         
  21       L.H. Zhang            2016   China      Asian       HB                         PCR-RFLP            hsa-*mir-146a*     175           302    37        86                52                            30         135    137                                                       0.697          \[[@B67]\]
                                                                                          hsa-*mir-196a-2*    175                302           25     85        65                42                            138        122                                               0.766                         
                                                                                          hsa-*mir-499*       175                302           115    49        11                197                           87         18                                                0.052                         
  22       Xin-wei Zhang         2011   China      Asian       PB                         PIRA-PCR            hsa-*mir-146a*     925           840    156       450               319                           151        386    303                                                       0.149          \[[@B68]\]
                                                                                          hsa-*mir-196a-2*    934                837           208    449       277               181                           417        239                                               0.972                         
  23       Bing Zhou             2014   China      Asian       NM                         Sequenom            hsa-*mir-146a*     266           281    40        153               73                            30         154    97             24            89            40             **0.007a**     \[[@B69]\]
                                                                                          hsa-*mir-196a-2*    266                281           93     139       34                66                            160        55     57             80            16            **0.019b**                    
                                                                                          hsa-*mir-499*       266                281           184    59        23                204                           61         16                                                **\<0.001a**                  
  24       Juan Zhou             2012   China      Asian       NM                         PCR-RFLP            hsa-*mir-146a*     186           483    33        86                67                            71         254    158                                                       0.056          \[[@B70]\]
                                                                                          hsa-*mir-499*       186                483           141    41        4                 371                           100        12                                                0.100                         
  25       Hong-Zhi Zou          2013   China      Asian       HB                         PCR-RFLP            hsa-*mir-499*      185           204    136       44                5                             139        52     13             54            14            3              0.060          \[[@B71]\]
  26       Xi-Dai Long           2016   China      Asian       HB                         Real-time PCR       hsa-*mir-146a*     1706          2270   464       858               384                           639        1187   444                                                       **0.011c**     \[[@B46]\]
                                                                                          hsa-*mir-196a-2*    1704               2270          484    867       353               718                           1138       414                                               0.318                         
                                                                                          hsa-*mir-499*       1706               2270          1073   492       141               1460                          598        212                                               **\<0.001c**                  
                                                                                          hsa-*mir-149*       1706               2270          1104   395       207               1503                          512        255                                               **\<0.001c**                  
  27       Rui Wang              2014   China      Asian       PB                         Sequenom            hsa-*mir-149*      172           267    21        68                83                            36         105    126            16            50            57             0.066          \[[@B72]\]
  28       Jia-Hui Qi            2014   China      Asian       PB                         HRM-PCR             hsa-*mir-146a*     314           406    0         165               149                           3          244    159                                                       **\<0.001a**   \[[@B73]\]
                                                                                          hsa-*mir-196a-2*    314                406           45     209       60                71                            214        121                                               0.156                         
                                                                                          hsa-*mir-499*       314                406           195    117       2                 301                           101        4                                                 0.157                         
  29       Yanyun Ma             2014   China      Asian       HB                         Sequenom            hsa-*mir-499*      981           969    724       241               16                            765        179    25             558           189           13             **\<0.001b**   \[[@B74]\]
  30       Yifang Han            2013   China      Asian       PB and HB mixed            qPCR                hsa-*mir-34b/c*    1013          999    451       444               118                           456        424    119                                                       0.183          \[[@B22]\]
                                                               qPCR                       hsa-*mir-196a-2*    1017               1009          207    505       305               220                           485        304                                               0.310          \[[@B75]\]     
  31       Myung Su Son          2013   Korea      Asian       HB                         PCR-RFLP            hsa-*mir-34b/c*    157           201    69        75                13                            110        74     17                                                        0.371          
  32       Yan Xu                2011   China      Asian       PB                         PCR-RFLP            hsa-*mir-34b/c*    502           549    204       236               62                            266        229    54                                                        0.647          \[[@B36]\]
  33       L.L. Chen             2016   China      Asian       HB                         PCR-RFLP            hsa-*mir-34b/c*    286           572    102       146               38                            272        267    33                                                        **0.002a**     \[[@B76]\]
  34       Pornpitra Pratedrat   2015   Thailand   Asian       PB                         Real-time PCR       hsa-*mir-101-1*    104           95     37        51                16                            39         43     13                                                        0.835          \[[@B77]\]
                                                                                          hsa-*mir-149*       104                95            11     27        66                9                             24         62                                                **0.010c**                    
  35       Olfat Shaker          2017   Egypt      Caucasian   NM                         Real-time PCR       hsa-*mir-101-1*    36            32     14        12                10                            11         20     1                                                         **0.029c**     \[[@B78]\]
  36       Z.Y. Sui              2016   China      Asian       HB                         Sequencing          let-7i             89            95     25        64                                              55                40                                                        0.482          \[[@B79]\]
  37       Fang Huang            2011   China      Asian       HB                         qPCR                let-7i             1261          1319   542       564               155                           581        585    153                                                       0.756          \[[@B80]\]

Abbreviations: HB, hospital based; HRM-PCR, high resolution melting-PCR; NM, not mentioned; PB, population based; PCR-RFLP, PCR-restriction fragment length polymorphism; PIRA-PCR, primer introduced restriction analysis--PCR.

qPCR, quantitative polymerase chain reaction. The bold values used in 'P of HWE in control group' means studies did not reach genetic equilibrium and were excluded in the following analysis.

Quantitative data synthesis of miRNA SNPs {#sec3-2}
-----------------------------------------

We found hsa-*mir-146a* rs2910164 was associated with a decreased HCC risk in the recessive model (*P*=0.017, OR = 0.90, 95%CI = 0.83--0.98; [Table 2](#T2){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}). While hsa-*mir-34b/c* rs4938723 was related with an increased HCC risk in the co-dominante model (*P*=0.016, OR = 1.19, 95%CI = 1.03--1.37). In the stratified analysis, individuals carrying hsa-*mir-146a* rs2910164 variant genotype were associated with a decreased HCC risk in the Asian population subgroup (*P*=0.017, OR = 0.90, 95%CI = 0.83--0.98) while individuals carrying hsa-*mir-196a-2* rs11614913 variant genotype were related with a decreased HCC risk in the Caucasian population subgroup (*P*=0.005, OR = 0.44, 95%CI = 0.25--0.78).

![Forest plot of ORs for the association of hsa-*mir-146a* and hsa-*mir-34b/c* polymorphism with HCC risks\
(**A**) hsa-*mir-146a* polymorphism stratified by ethnicity in recessive model; (**B**) hsa-*mir-34b/c* polymorphism in co-dominant model (heterozygote compared with wild-type).](bsr-38-bsr20180712-g2){#F2}

###### Meta-analysis of the association between common SNPs and HCC risk

  Stratification     *n*   Heterozygote compared with wild-type   Mutation homozygote compared with wild-type   Dominant model   Recessive model    Allelic model                                                                                                              
  ------------------ ----- -------------------------------------- --------------------------------------------- ---------------- ------------------ --------------- --------- -------------- ------- --------- ------------------ ----------- --------- -------------- ------- ---------
  hsa-*mir-146a*     15    0.98                                   0.812                                         20.4             0.90               0.297           59.4^1^   0.94           0.472   50.0^1^   **0.90**           **0.017**   40.7      1.05           0.315   61.2^1^
  rs2910164 G/C            (0.88--1.10)                                                                                          (0.73--1.10)                                 (0.80--1.11)                     **(0.83--0.98)**                         (0.95--1.16)           
   Asians            14    0.97                                   0.636                                         22.4             0.89               0.306           62.3^1^   0.93           0.383   52.1^1^   **0.90**           **0.017**   44.9      1.06           0.272   63.2^1^
                           (0.87--1.09)                                                                                          (0.71--1.11)                                 (0.78--1.10)                     **(0.83--0.98)**                         (0.96--1.18)           
   Caucasian         1     1.18                                   0.430                                         NA               0.96               0.920           NA        1.45           0.491   NA        0.91               0.823       NA        0.92           0.619   NA
                           (0.79--1.76)                                                                                          (0.39--2.32)                                 (0.78--1.69)                     (0.38--2.18)                             (0.67--1.27)           
  hsa-*mir-196a-2*   14    1.00                                   0.992                                         53.4^1^          0.86               0.179           73.5^1^   0.96           0.636   64.9^1^   0.88               0.122       72.1^1^   1.06           0.244   74.0^1^
  rs11614913 C/T           (0.87--1.15)                                                                                          (0.70--1.07)                                 (0.83--1.12)                     (0.74--1.04)                             (0.96--1.18)           
   Asians            12    0.99                                   0.929                                         50.2^1^          0.92               0.420           73.2^1^   0.97           0.703   63.9^1^   0.92               0.305       72.0^1^   1.05           0.400   74.1^1^
                           (0.87--1.14)                                                                                          (0.70--1.07)                                 (0.83--1.13)                     (0.78--1.08)                             (0.94--1.16)           
   Caucasian         2     1.17                                   0.743                                         82.8^1^          **0.44**           **0.005**       0.0       0.99           0.976   83.0^1^   **0.47**           **0.005**   0.0       1.19           0.517   73.8^1^
                           (0.46--2.97)                                                                                          **(0.25--0.78)**                             (0.40--2.42)                     **(0.28--0.79)**                         (0.70--2.02)           
  hsa-*mir-499*      13    1.10                                   0.376                                         67.4^1^          1.04               0.850           58.3^1^   1.11           0.410   76.7^1^   1.04               0.829       48.6^3^   0.92           0.418   81.0^1^
  rs3746444 A/G            (0.89--1.37)                                                                                          (0.71--1.51)                                 (0.87--1.40)                     (0.75--1.43)                             (0.74--1.13)           
   Asians            11    1.14                                   0.264                                         70.7^1^          1.07               0.779           63.9^1^   1.15           0.315   79.4^1^   1.04               0.861       56.0^1^   0.89           0.367   83.4^1^
                           (0.90--1.45)                                                                                          (0.67--1.71)                                 (0.88--1.40)                     (0.68--1.57)                             (0.70--1.14)           
   Caucasian         2     0.87                                   0.448                                         0.0              1.00               0.993           2.5       0.91           0.613   11.1      1.09               0.632       0.0       1.000          1.000   41.1
                           (0.58--1.29)                                                                                          (0.65--1.55)                                 (0.63--1.31)                     (0.77--1.54)                             (0.80--1.26)           
  hsa-*mir-149*      7     0.97                                   0.696                                         16.6             1.03               0.882           68.2^1^   0.99           0.962   56.6^1^   1.03               0.828       61.1^1^   1.02           0.670   73.4^1^
  rs2292832 C/T            (0.82--1.14)                                                                                          (0.72--1.47)                                 (0.77--1.28)                     (0.81--1.30)                             (0.93--1.12)           
  hsa-*mir-34b/c*    3     **1.19**                               **0.016**                                     52.6^2^          1.15               0.221           20.4      1.25           0.065   58.6^1^   1.06               0.580       0.0       0.87           0.100   54.2^1^
  rs4938723 T/C            **(1.03--1.37)**                                                                                      (0.92--1.44)                                 (0.99--1.58)                     (0.86--1.31)                             (0.74--1.03)           

The results were in bold, if *P*\<0.05.

^1^, means the heterogeneity exists and random-effect model based on DerSimonian and Laird method was used, otherwise, a fixed-effect model based on the Mantel--Haenszel method was employed.

^2^, *P*~heterogeneity~ is 0.121 which is higher than 0.10, thus fixed model is used.

^3^, *P*~heterogeneity~ is 0.025 which is lower than 0.10, thus random model is used.

When analyzing the HBV-related HCC risk, we found that hsa-*mir-196a-2* rs11614913 was associated with a decreased HBV-related HCC risk in the co-dominant and allelic models (CT compared with CC: *P*=0.003, OR = 0.75, 95%CI = 0.62--0.91; TT compared with CC: *P*=0.036, OR = 0.61, 95%CI = 0.39--0.97; T compared with C: *P*=0.031, OR = 0.80, 95%CI = 0.65--0.98). And hsa-*mir-149* rs2292832 was found to be associated with a decreased HBV-related HCC risk in the dominant and recessive models (dominant: *P*=0.049, OR = 0.28, 95%CI = 0.08--0.99; recessive: *P*=0.012, OR = 0.28, 95%CI = 0.10--0.75, [Table 3](#T3){ref-type="table"} and [Figure 3](#F3){ref-type="fig"}).

![Forest plot of ORs for the association of hsa-*mir-196a-2* and hsa-*mir-149* polymorphism with HCC risks\
(**A**) hsa-*mir-196a-2* polymorphism stratified by ethnicity in co-dominant model (heterozygote compared with wild-type); (**B**) hsa-*mir-196a-2* polymorphism stratified by ethnicity in co-dominant model (mutation homozygote compared with wild-type); (**C**) hsa*-mir-149* polymorphism in dominant model; (**D**) hsa-*mir-149* polymorphism in recessive model.](bsr-38-bsr20180712-g3){#F3}

###### Meta-analysis of the association between common SNPs and HBV related-HCC risk

  Stratification     *n*   Heterozygote compared with wild-type   *n*         Mutation homozygote compared with wild-type   *n*   Dominant model     *n*         Recessive model   *n*   Allelic model                                                                                                            
  ------------------ ----- -------------------------------------- ----------- --------------------------------------------- ----- ------------------ ----------- ----------------- ----- ------------------ ----------- --------- --- ------------------ ----------- --------- --- ------------------ ----------- ---------
  hsa-*mir-146a*     6     1.05                                   0.627       21.9                                          6     0.86               0.178       8.8               6     0.99               0.950       39.2      7   0.87               0.066       0.0       7   0.95               0.281       26.3
  rs2910164 G/C            (0.86--1.28)                                                                                           (0.69--1.07)                                           (0.82--1.20)                                 (0.75--1.01)                                 (0.86--1.05)                   
   Asians            5     0.97                                   0.813       0.0                                           5     0.85               0.161       24.9              5     0.92               0.434       24.4      6   0.87               0.067       0.0       6   0.93               0.144       12.6
                           (0.78--1.22)                                                                                           (0.68--1.07)                                           (0.75--1.13)                                 (0.75--1.01)                                 (0.83--1.03)                   
   Caucasian         1     1.46                                   0.105       NA                                            1     1.05               0.930       NA                1     1.40               0.132       NA        1   0.91               0.862       NA        1   1.25               0.232       NA
                           (0.92--2.31)                                                                                           (0.37--2.94)                                           (0.90--2.18)                                 (0.33--2.53)                                 (0.87--1.80)                   
  hsa-*mir-196a-2*   4     **0.75**                               **0.003**   9.5                                           4     **0.61**           **0.036**   62.3^1^           5     0.86               0.444       76.4^1^   5   0.86               0.429       70.5^1^   4   **0.80**           **0.031**   60.4^1^
  rs11614913 C/T           **(0.62--0.91)**                                                                                       **(0.39--0.97)**                                       (0.58--1.27)                                 (0.58--1.26)                                 **(0.65--0.98)**               
   Asians            3     **0.76**                               **0.009**   38.1                                          3     0.70               0.153       62.3^1^           4     0.94               0.805       80.5^1^   4   0.97               0.861       68.5^1^   3   0.85               0.130       58.0^1^
                           **(0.62--0.93)**                                                                                       (0.43--1.14)                                           (0.59--1.50)                                 (0.66--1.42)                                 (0.68--1.05)                   
   Caucasian         1     0.70                                   0.174       NA                                            1     **0.35**           **0.007**   NA                1     **0.59**           **0.034**   NA        1   **0.42**           **0.019**   NA        1   **0.61**           **0.006**   NA
                           (0.41--1.17)                                                                                           **(0.16--0.75)**                                       **(0.36--0.96)**                             **(0.21--0.87)**                             **(0.43--0.87)**               
  hsa-*mir-499*      4     0.81                                   0.351       52.4^1^                                       4     0.85               0.769       68.1^1^           5     1.08               0.833       85.6^1^   4   0.90               0.818       55.5^1^   5   0.90               0.633       76.1^1^
  rs3746444 A/G            (0.52--1.27)                                                                                           (0.28--2.56)                                           (0.55--2.12)                                 (0.36--2.24)                                 (0.59--1.38)                   
  hsa-mir-149        3     0.37                                   0.059       88.7^1^                                       3     0.14               0.071       95.6^1^           3     **0.28**           **0.049**   93.3^1^   4   **0.28**           **0.012**   91.5^1^   3   0.38               0.057       96.0^1^
  rs2292832 C/T            (0.13--1.04)                                                                                           (0.02--1.18)                                           **(0.08--0.99)**                             **(0.10-0.75)**                              (0.14--1.03)                   

The results were in bold, if *P*\<0.05.

^1^, means the heterogeneity exists and random-effect model based on DerSimonian and Laird method was used, otherwise, a fixed-effect model based on the Mantel--Haenszel method was employed.

Other miRNA SNPs and HCC risk {#sec3-3}
-----------------------------

The association of some polymorphisms with HCC risk could not be evaluated because of the limited number of studies (such as hsa-*mir-101-1* rs7536540 and hsa-let-7i rs10877887). We reviewed these miRNA SNPs that have been studied for HCC cancer risk ([Table 4](#T4){ref-type="table"}). These may prove informative in the future study of HCC-associated miRNA polymorphism biomarkers.

###### Other SNPs conferring in the studies of HCC risk

  Number   hsa-mirNA           SNP           Results                                                              Citation
  -------- ------------------- ------------- -------------------------------------------------------------------- ------------
  1        hsa-*mir-646*       rs6513497     The variant allele decreased HCC risk                                \[[@B81]\]
  2        hsa-*mir-122*       rs4309483     The variant allele increased HCC risk in HBV carriers                \[[@B48]\]
  3        hsa-*mir-378*       rs1076064     The variant allele decreased HCC risk in HBV carriers                \[[@B82]\]
  4        hsa-*mir-501*       rs112489955   The variant allele decreased HCC risk                                \[[@B47]\]
  5        hsa-*mir-608*       rs4919510     No association                                                       \[[@B72]\]
  6        hsa-*mirNA3152*     rs13299349    The variant allele increased HCC risk                                \[[@B83]\]
  7        hsa-*mirNA449b*     rs10061133    The variant allele increased HCC risk                                \[[@B83]\]
  8        hsa-*mir-106b-25*   rs999885      The variant genotype increased HCC risk in HBV persistent carriers   \[[@B84]\]
  9        hsa-*mir-199a*      rs74723057    No association                                                       \[[@B85]\]
  10       hsa-*mir-301b*      rs384262      No association                                                       \[[@B73]\]
  11       hsa-*mir-423*       rs6505162     No association                                                       \[[@B74]\]
  12       hsa-*mir-221*       rs17084733    No association                                                       \[[@B78]\]
  13       hsa-*mir-1269a*     rs73239138    The variant allele increased HCC risk                                \[[@B86]\]

Heterogeneity {#sec3-4}
-------------

Heterogeneity between studies was observed in [Table 2](#T2){ref-type="table"}. Some comparisons showed slight or moderate heterogeneity between studies. We subsequently conducted sensitivity analyses by estimating sensitivity before and after removal of each study from the analysis (Supplementary Table S1). The most influencing single study was the study conducted by Han et al. \[[@B22]\] for hsa-*mir-34b/c* rs4938723. However, sensitivity analysis results ranged from insignificant to statistically significant for the allele comparison because the ORs (95%CI) were 0.87 (0.73--1.03) before removal of the study by Han et al. \[[@B22]\] and 0.79 (0.67--0.92) after removal of that study.

Publication bias {#sec3-5}
----------------

We used Begg's and Egger's tests to evaluate the potential publication bias of included studies. For hsa-*mir-149* rs2292832, a significant *P*\<0.05 was observed in the three genetic models ([Table 5](#T5){ref-type="table"}), indicating potential publication bias. As reported, this may be due to language bias, a flawed methodological design for smaller studies or a lack of publication of small trials with opposing results \[[@B9]\].

###### The results of Begg's and Egger's tests for the publication bias

  Comparison type                               Begg's test   Egger's test           
  --------------------------------------------- ------------- -------------- ------- -----------
  hsa-*mir-146a* rs2910164 G/C                                                       
  Heterozygote compared with wild-type          −0.64         0.520          0.71    0.490
  Mutation homozygote compared with wild-type   0.05          0.961          −0.47   0.648
  Dominant model                                −0.54         0.586          0.43    0.673
  Recessive model                               1.14          0.255          −1.44   0.173
  Allelic model                                 −0.94         0.347          0.80    0.435
  hsa-*mir-196a-2* rs11614913 C/T                                                    
  heterozygote compared with wild-type          0.49          0.622          0.38    0.710
  mutation homozygote compared with wild-type   −1.15         0.250          1.33    0.209
  Dominant model                                −0.05         0.956          0.84    0.418
  Recessive model                               −1.04         0.298          1.30    0.216
  Allelic model                                 0.60          0.547          −1.08   0.300
  hsa-*mir-499* rs3746444 A/G                                                        
  Heterozygote compared with wild-type          −1.59         0.113          1.78    0.103
  Mutation homozygote compared with wild-type   −0.73         0.464          0.17    0.865
  Dominant model                                −1.22         0.222          1.25    0.237
  Recessive model                               −0.61         0.542          0.43    0.673
  Allelic model                                 1.22          0.222          −0.86   0.410
  hsa-*mir-149* rs2292832 T/C                                                        
  Heterozygote compared with wild-type          0.75          0.453          −1.08   0.331
  Mutation homozygote compared with wild-type   1.95          **0.051**      −3.08   **0.028**
  Dominant model                                1.05          0.293          −1.26   0.263
  Recessive model                               1.65          **0.099**      −2.80   **0.038**
  Allelic model                                 −1.95         **0.051**      2.66    **0.045**
  hsa-*mir-34b/c* rs4938723 T/C                                                      
  Heterozygote compared with wild-type          1.57          0.117          −1.44   0.387
  Mutation homozygote compared with wild-type   0.52          0.602          −0.21   0.867
  Dominant model                                0.52          0.602          −0.99   0.504
  Recessive model                               0.52          0.602          −0.04   0.977
  Allelic model                                 −0.52         0.602          0.63    0.641

The bold numeric means significant as \<0.100.

FPRP analyses and trial sequential analysis {#sec3-6}
-------------------------------------------

We calculated the FPRP values for all observed significant findings in the overall HCC risk. With the assumption of a prior probability of 0.1, the FPRP values in the hsa-*mir-146* rs2910164 recessive model for the overall risk and the Asian subgroups, and in the hsa-*mir-196a-2* rs11614913 recessive model for the Caucasian subgroup were all \<0.20, suggesting that these significant associations were noteworthy ([Table 6](#T6){ref-type="table"}).

###### FPRP values for the associations between hsa-miRNA polymorphisms and HCC risk

  Variables                                       OR (95%CI)          *P*[^1^](#T6TFN1){ref-type="table-fn"}   Power[^2^](#T6TFN2){ref-type="table-fn"}   Prior probability                               
  ----------------------------------------------- ------------------- ---------------------------------------- ------------------------------------------ ------------------- ----------- ------- ------- -------
  hsa-*mir-146* rs2910164                                                                                                                                                                                 
    Recessive model                                                                                                                                                                                       
    Overall                                       0.90 (0.83--0.98)   0.017                                    0.888                                      **0.054**           **0.147**   0.655   0.950   0.995
    Asians                                        0.90 (0.83--0.98)   0.017                                    0.870                                      **0.055**           **0.150**   0.659   0.951   0.995
  hsa-*mir-196a*-2 rs11614913                                                                                                                                                                             
    Mutation homozygote compared with wild-type                                                                                                                                                           
    Caucasian                                     0.44 (0.25--0.78)   0.005                                    0.152                                      **0.090**           0.228       0.765   0.970   0.997
    Recessive model                                                                                                                                                                                       
    Caucasian                                     0.47 (0.28--0.79)   0.005                                    0.726                                      **0.020**           **0.058**   0.405   0.873   0.986
  hsa-*mir-34b/c* rs4938723                                                                                                                                                                               
    Heterozygote compared with wild-type                                                                                                                                                                  
    Overall                                       1.19 (1.03--1.37)   0.016                                    0.353                                      **0.120**           0.290       0.818   0.978   0.998

PB, source of controls is population-based.

Chi-square test was adopted to calculate the genotype frequency distributions.

Statistical power was calculated using the number of observations in the subgroup and the OR and *P*-values in this table.

The bold numeric values were considered significant as \<0.20.

Amongst the positive results we found, the recessive model for hsa-*mir-146a* was adopted for the trial sequential analysis to strengthen the robustness of our findings. According to TSA result, the required information size was 15021 subjects to demonstrate the issue ([Figure 4](#F4){ref-type="fig"}). Until now, the cumulative z-curve has not crossed the trial monitoring boundary before reaching the required information size, indicating that the cumulative evidence is insufficient and further trials are necessary.

![The required information size to demonstrate the relevance of hsa-*mir-146a* polymorphism with risk of HCC (recessive model)](bsr-38-bsr20180712-g4){#F4}

Discussion {#sec4}
==========

Until now, there was only one similar meta-analysis published \[[@B23]\] and we had many advantages than theirs. First, the latest update date, we searched until 23 February 2018 and there were 37 studies included in this meta-analysis. Second, we considered the available data for the HBV-related HCC risk and supplied more promising SNP sites for the precaution of HBV-related HCC risk. Third, we listed all the genotypes of the case and control groups and considered the *P*-value of HWE. There existed two problems for the research state quo: in the studying field of miRNA polymorphisms, (i) the major genotype has not the more frequencies than the minor one, which made the meta results negative. For example, hsa-*mir-149* A\>G SNP was reported as 13, 36, 139 for AA, AG, GG genotype by Chu et al. \[[@B24]\] and as 210, 49, 12 for AA, AG, GG genotype by Kou et al. \[[@B25]\], while the genotyping method for them was the same. Here, we suppose the reasons for this phenomenon are the geographical and ethnicity cause and the unstable genotyping method. (ii) The Hardy--Weinberg principle was a basic law for the genetic studies. We found several studies did not mention HWE when the *P*~HWE~\<0.05. In our meta-analysis, we checked the *P*-value of HWE in the control group and if *P*~HWE~\<0.05, the SNP should be discarded in further analysis. In addition, we followed main directions from the guidelines for the miRNA terminology \[[@B26]\].

The position of miR-SNPs included pri-, pre-, and/or mature miRNA, and the function of the miR-SNPs depended on its position \[[@B27]\]. The pre-miR-SNPs included hsa-*mir-146a* rs2910164, hsa-*mir-196a-2* rs11614913, hsa-*mir-499* rs3746444, hsa-*mir-149* rs2292832, and hsa-*mir-27a* rs895819. Others were all pri-miR-SNPs.

In this disordered reported circumstance, we still found hsa-*mir-146a* rs2910164 and hsa-*mir-34b/c* rs4938723 had potential to be biomarkers for the HCC risk in these five common miR-SNPs. First, we found hsa-*mir-146a* rs2910164 was associated with a decreased risk of HCC. The mature hsa-*mir-146a* could function for cancer cell proliferation, apoptosis, invasion, and metastasis \[[@B28]\]. miR-SNP rs2910164 is a G to C variation located at the +4 base of the passenger strand of hsa-*mir-146a-3p*. In addition, this SNP decreases the minimum free energy (MFE) from −41.80 kcal/mol for the G allele to −38.80 kcal/mol for the C allele, suggesting a less stable secondary structure for the variant C allele. Jazdzewski et al. \[[@B32]\] reported that the variant (C) genotype shows lower levels of the oncogeneic hsa-*mir-146a* expression, all the above may be the reasons the variant C had a protective role for HCC risk. Second, we found that hsa-*mir-34b/c* rs4938723 was associated with an increased HCC risk. This rs4938723 located within the typical CpG island region of pri-hsa-*mir-34b/c*, and methylation of hsa*-mir-34b/c* CpG islands were reported to be associated with several cancers \[[@B33]\]. The T→C variation of this polymorphism has been predicted to create a GATA-binding site and could affect the transcription factor GATA activity and further affect the mature hsa-*mir-34b/c* expression \[[@B36]\], which may be the reason for the rs4938723 associated with HCC risk.

The etiology of HBV-related HCC was not caused by one particular driver mutation but involved several oncogenic pathways \[[@B37],[@B38]\]. It included TP53 pathway \[[@B39]\], Wnt signaling \[[@B37]\], cell cycle \[[@B40],[@B41]\], oxidative stress \[[@B39],[@B42]\], epigenetic regulator \[[@B40]\], and so on. Thus, many miRNAs play important role for these oncogenic pathways in HBV-related HCC \[[@B43],[@B44]\]. We found in this meta-analysis, hsa-*mir-196a-2* rs11614913 and hsa-*mir-149* rs2292832 were associated with decreased HBV-related HCC risks. However, there is no report about the hsa-*mir-196a-2* and hsa-*mir-149* involved in the process of HBV-related HCC. Some other miRNAs like hsa-*mir-125* were found to be associated with HBV-related HCC \[[@B45]\]. The results we found could be a clue for the particular miRNA involved in the pathogenic process and it also need to be verified in the future studies.

Some promising miR-SNPs were summarized in [Table 5](#T5){ref-type="table"}. Several SNPs were associated with HCC risk and related functional studies were also reported. For example, Long et al. \[[@B46]\] screened 48 pre-miRNA SNPs and found only hsa-*mir-1268a* rs28599926 affected HCC risk. And this polymorphism was associated not only with higher portal vein tumor risk and tumor dedifferentiation, but also with increasing the mutation risk of *TP53* gene and modifying the targetted *ADAMTS4* gene expression \[[@B46]\]. Several miR-SNPs were also found to affect the miRNA or gene expression, like hsa-*mir-501* SNP and hsa-*mir-122* SNP \[[@B47],[@B48]\]. These are all the potential functional polymorphism biomarkers for the future HCC studies.

Advantages and limitations {#sec4-1}
--------------------------

This meta-analysis still had several limitations. First, only studies written in English and Chinese were searched in our analysis, while reports in other languages or some other ongoing studies were not available. Second, the pooled sample size was relatively limited and thus limited for the subgroup analysis. More studies are still required to pool together to make the analysis more reliable.

Summary and future directions {#sec4-2}
-----------------------------

In summary, we found hsa-*mir-146a* rs2910164 was associated with a decreased HCC risk in the recessive model. While hsa-*mir-34b/c* rs4938723 was related with an increased HCC risk in the co-dominant. When analyzing the HBV-related HCC risk, hsa-*mir-196a-2* rs11614913 was associated with a decreased HBV-related HCC risk in the co-dominant and allelic models, and hsa-*mir-149* rs2292832 was found to be associated with a decreased HBV-related HCC risk in the dominant and recessive models. In conclusion, hsa-*mir-146a* rs2910164 and hsa-*mir-34b/c* rs4938723 could be biomarkers for the HCC risk while hsa-*mir-196a-2* rs11614913 and hsa-*mir-149* rs2292832 had potential to be biomarkers for HBV-related HCC risk.
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